Cribstone Capital Management’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-750
Closed 828
2018
Q1
$0 Hold
750
﹤0.01% 879
2017
Q4
$0 Hold
750
﹤0.01% 911
2017
Q3
$0 Hold
750
﹤0.01% 765
2017
Q2
$0 Hold
750
﹤0.01% 764
2017
Q1
$0 Buy
+750
New ﹤0.01% 774

Cribstone Capital Management's ONCY Position: Q2 2018 in Review

Cribstone Capital Management sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q2 2018, closing a stake of 750 shares.

Cribstone Capital Management first reported a position in ONCY in Q1 2017 and held it in 5 quarters. The position peaked at $0 in Q1 2018. 0 funds tracked by Wall St. Rank hold ONCY as of Q2 2018.

  • Cribstone Capital Management reported no remaining ONCOLYTICS BIOTECH INC position as of Q2 2018 after selling out during the quarter.
  • Cribstone Capital Management sold 750 ONCOLYTICS BIOTECH INC shares in Q2 2018.
  • Cribstone Capital Management first reported a position in ONCOLYTICS BIOTECH INC in Q1 2017 and held it in 5 quarters.
  • Cribstone Capital Management's ONCOLYTICS BIOTECH INC position peaked at $0 in Q1 2018.
  • 0 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q2 2018.

Based on Cribstone Capital Management's 13F filing for Q2 2018, filed 24 Jul 2018.